Subscribe to our newsletter and stay informed

Check out our list of top companies

Check out our carefully compiled lists of the most relevant and impactful companies within their fields.

Check out our list of top unicorns

Read and learn about the biggest companies that various countries have produced, how they made it, and what the future looks like for them.

Novo Nordisk Funds AI Supercomputer for Medical Innovation

Novo Nordisk, renowned for Ozempic and Wegovy, spearheads funding for a cutting-edge supercomputer
March 21, 2024

In a move poised to revolutionize medical research, Novo Nordisk, the renowned pharmaceutical giant behind game-changing drugs like Ozempic and Wegovy, is steering its resources towards groundbreaking innovation. The company's investment is propelling the creation of a cutting-edge supercomputer, leveraging Nvidia's artificial intelligence prowess, with a singular mission: to unlock new frontiers in medicine and treatment modalities.

The Novo Nordisk Foundation has inked a significant deal with France's Eviden to construct what promises to be one of the globe's most formidable supercomputers. Fueled by Nvidia's AI technology, this powerhouse of computation is slated to process colossal datasets, heralding a new era of accelerated scientific breakthroughs.

Cédric Bourrasset, Eviden’s head of quantum computing, hailed the venture as a game-changer, asserting that the supercomputer, christened Gefion, holds the key to catalyzing transformative discoveries in drug development, disease diagnosis, and therapeutic interventions.

Set to commence pilot projects by year-end, Gefion will find its home in Denmark's national hub for AI innovation. With open access extended to researchers from both public and private domains in Denmark, this initiative is poised to spark a surge of collaborative endeavors aimed at propelling medical science forward.

The backing of industry giants adds weight to this endeavor, with Nvidia's cutting-edge chip technology set to power Gefion's computational prowess. Meanwhile, the Novo Nordisk Foundation, boasting a significant stake in Novo Nordisk, underscores the profound impact this collaboration could have on medical research.

As the world grapples with complex medical challenges, the convergence of AI and supercomputing offers a glimmer of hope. Novo Nordisk's visionary investment in Gefion represents a bold step towards harnessing technology's full potential in healthcare. With the promise of accelerated scientific breakthroughs on the horizon, Gefion stands as a beacon of innovation, poised to illuminate the path towards a healthier future.

More about: 

Last related articles

chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram